| BNCRemoval from Official List at COB 03/02/2014 |
| 03/02/14 | | 27.04KB | Share |
|
| BNCSuspension from Official Quotation cob 28/01/2014 |
| 28/01/14 | PRICE SENSITIVE | 80.2KB | Share |
|
| BNCChange of Director's Interest Notice |
| 22/01/14 | | 111.89KB | Share |
|
| BNCAMENDED Appendix 3B |
| 13/01/14 | | 123.89KB | Share |
|
| BNCBioniche Life Sciences Appoints New Chief Operating Officer |
| 08/01/14 | | 32.9KB | Share |
|
| BNCAppendix 3B |
| 08/01/14 | | 120.45KB | Share |
|
| BNCCDI Holder De-listing Package |
| 23/12/13 | | 209.88KB | Share |
|
| BNCBioniche Life Sciences Inc. Delisting Approved by the ASX |
| 12/12/13 | | 204.74KB | Share |
|
| BNCAppendix 3B |
| 10/12/13 | | 120.49KB | Share |
|
| BNCIllness Related to E. coli O157 Costs $403.9 in Canada |
| 05/12/13 | | 72.31KB | Share |
|
| BNCBioniche Announces its Intention to Delist from the ASX |
| 02/12/13 | PRICE SENSITIVE | 31.64KB | Share |
|
| BNCBioniche Horse Product Approved for Sale in the U.S. |
| 02/12/13 | PRICE SENSITIVE | 71.55KB | Share |
|
| BNCChange of Director's Interest Notice |
| 19/11/13 | | 73.03KB | Share |
|
| BNCMaterial Change Report |
| 15/11/13 | PRICE SENSITIVE | 70.04KB | Share |
|
| BNCInitial Director's Interest Notice |
| 11/11/13 | | 36.16KB | Share |
|
| BNCFinal Director's Interest Notice |
| 11/11/13 | | 96.44KB | Share |
|
| BNCSummary of Material Terms of Employment Contract with CEO |
| 08/11/13 | | 33.87KB | Share |
|
| BNCAppendix 3B |
| 08/11/13 | | 118.66KB | Share |
|
| BNC2013 Annual General Meeting Voting Results |
| 08/11/13 | | 15.12KB | Share |
|
| BNCQ1 F2014 MD&A, Financials & Certificates |
| 07/11/13 | | 354.39KB | Share |
|
| BNCBioniche Reports Fiscal 2014 Fiscal Q1 Results |
| 06/11/13 | PRICE SENSITIVE | 78.37KB | Share |
|
| BNCAGM Presentation |
| 06/11/13 | | 623.28KB | Share |
|
| BNCBioniche Life Sciences Announces New CEO |
| 05/11/13 | PRICE SENSITIVE | 33.99KB | Share |
|
| BNCBioniche 2013 Proxy Circular Available |
| 21/10/13 | | 33.22KB | Share |
|
| BNCBioniche Provides Update on Plans for New Drug Submission |
| 08/10/13 | PRICE SENSITIVE | 41.25KB | Share |
|
| BNCNotice of Annual & Special Meeting/Proxy Form |
| 04/10/13 | | 440.54KB | Share |
|
| BNCAppendix 3B |
| 04/10/13 | | 126.96KB | Share |
|
| BNCAnnual Report to shareholders |
| 04/10/13 | | 2.16MB | Share |
|
| BNCChange of Director's Interest Notices |
| 03/10/13 | | 233.19KB | Share |
|
| BNCF2013 Annual Information Form |
| 01/10/13 | | 1.61MB | Share |
|
| BNCFiscal 2013 MD&A and Audited Financial Statements |
| 01/10/13 | | 853.12KB | Share |
|
| BNCBioniche Reports Fiscal 2013 Year-End Results |
| 30/09/13 | PRICE SENSITIVE | 229.62KB | Share |
|
| BNCChange of Director's Interest Notice |
| 30/09/13 | | 111.69KB | Share |
|
| BNCWarrant Indenture |
| 27/09/13 | | 376.03KB | Share |
|
| BNCChange of Director's Interest Notice |
| 27/09/13 | | 72.34KB | Share |
|
| BNCBioniche Closes Equity Offering and Private Placement |
| 27/09/13 | | 65.86KB | Share |
|
| BNCBioniche Files Final Prospectus for Canadian Equity Offering |
| 20/09/13 | | 218.92KB | Share |
|
| BNCShort Form Prospectus |
| 19/09/13 | PRICE SENSITIVE | 426.04KB | Share |
|
| BNCAmended Material Change Report |
| 19/09/13 | | 40.12KB | Share |
|
| BNCInitial Director's Interest Notice |
| 17/09/13 | | 16.95KB | Share |
|
| BNCDisclosure Document |
| 13/09/13 | | 127.52KB | Share |
|
| BNCMaterial Change Report |
| 12/09/13 | | 38.24KB | Share |
|
| BNCBioniche CEO Announces his New Role with the Company |
| 12/09/13 | PRICE SENSITIVE | 67.13KB | Share |
|
| BNCBioniche and Concerned Shareholders Announce a Settlement |
| 12/09/13 | PRICE SENSITIVE | 69.41KB | Share |
|
| BNCChange of Director's Interest Notice |
| 09/09/13 | | 75.7KB | Share |
|
| BNCAppendix 3B |
| 09/09/13 | | 119.28KB | Share |
|
| BNCMaterial Change Report |
| 19/08/13 | | 243.42KB | Share |
|
| BNCChange of Director's Interest Notice |
| 09/08/13 | | 75.78KB | Share |
|
| BNCAppendix 3B |
| 09/08/13 | | 121.62KB | Share |
|
| BNCPreliminary Short Form Prospectus for Canadian Offering |
| 08/08/13 | PRICE SENSITIVE | 470.57KB | Share |
|
| BNCBioniche Confirms Pricing of Canadian Equity Offering |
| 08/08/13 | PRICE SENSITIVE | 67.05KB | Share |
|
| BNCTrading Halt |
| 07/08/13 | PRICE SENSITIVE | 111.35KB | Share |
|
| BNCLicence Agreement |
| 07/08/13 | | 212.82KB | Share |
|
| BNCAmended and Restated Loan Agreement with Paladin Labs |
| 07/08/13 | | 914.6KB | Share |
|
| BNCBioniche Files Prospectus for Canadian Equity Offering |
| 07/08/13 | PRICE SENSITIVE | 72.49KB | Share |
|
| BNCOntario Court Confirms Timing of Bioniches AGM |
| 24/07/13 | | 64.43KB | Share |
|
| BNCBioniche's Folltropin Gains Access To Additional Markets |
| 16/07/13 | PRICE SENSITIVE | 64.78KB | Share |
|
| BNCAMENDED Appendix 3B |
| 12/07/13 | | 128.7KB | Share |
|
| BNCChange of Director's Interest Notices |
| 11/07/13 | | 188.42KB | Share |
|
| BNCHealth Canada Provides Direction to Bioniche Re Urocidin |
| 09/07/13 | PRICE SENSITIVE | 40.84KB | Share |
|
| BNCAppendix 3B |
| 08/07/13 | | 119.08KB | Share |
|
| BNCBioniche deal closes with Paladin |
| 08/07/13 | PRICE SENSITIVE | 47.67KB | Share |
|
| BNCAppendix 3B |
| 05/07/13 | | 112.12KB | Share |
|
| BNCChange of Director's Interest Notice |
| 05/07/13 | | 75.72KB | Share |
|
| BNCDissident Shareholder Notice of Meeting |
| 03/07/13 | | 1.07MB | Share |
|
| BNCBioniche Responds to Dissident Shareholders Latest Tactics |
| 01/07/13 | | 66.21KB | Share |
|
| BNCBioniche VMC Validation Update |
| 28/06/13 | | 64.58KB | Share |
|
| BNCChange of Director's Interest Notice |
| 26/06/13 | | 71.89KB | Share |
|
| BNCShareholder Newsletter |
| 26/06/13 | | 6.83MB | Share |
|
| BNCAmended and Restated Revenue Interest Agreement |
| 17/06/13 | | 2.54MB | Share |
|
| BNCBioniche Founder and CEO Addresses Shareholders |
| 13/06/13 | | 76.2KB | Share |
|
| BNCMaterial Document - Disclosure Document |
| 13/06/13 | | 50.52KB | Share |
|
| BNCMaterial Change Report - Disclosure Document |
| 13/06/13 | | 58.87KB | Share |
|
| BNCAppendix 3B |
| 06/06/13 | | 112.18KB | Share |
|
| BNCChange of Director's Interest Notice |
| 06/06/13 | | 75.87KB | Share |
|
| BNCPaladin Labs and Bioniche Life Sciences Sign Deals |
| 06/06/13 | PRICE SENSITIVE | 48.58KB | Share |
|
| BNCBioniche Responds to Shareholders and Rejects Early Meeting |
| 30/05/13 | | 64.82KB | Share |
|
| BNCChange of Director's Interest Notices |
| 24/05/13 | | 188.73KB | Share |
|
| BNCBecoming a substantial holder - Release date amended |
| 20/05/13 | | 30.32KB | Share |
|
| BNCAMENDED Appendix 3B |
| 17/05/13 | | 113.31KB | Share |
|
| BNCBioniche Engages Evercore Partners |
| 14/05/13 | PRICE SENSITIVE | 67.23KB | Share |
|
| BNCF2013 Q3 Letter to Shareholders, MD&A, Financials & Certific |
| 10/05/13 | | 382.35KB | Share |
|
| BNCBioniche Life Sciences Inc. Reports Q3, Fiscal 2013 Results |
| 09/05/13 | PRICE SENSITIVE | 135.45KB | Share |
|
| BNCBioniche Responds to Request for Shareholder Meeting |
| 06/05/13 | | 65.2KB | Share |
|
| BNCAppendix 3B |
| 06/05/13 | | 111.52KB | Share |
|
| BNCChange of Director's Interest Notice |
| 06/05/13 | | 75.82KB | Share |
|
| BNCBioniche Acknowledges Request for Shareholder Meeting |
| 29/04/13 | | 62.02KB | Share |
|
| BNCBioniche Responds to Letter from Former Biovail Executives |
| 23/04/13 | | 64.54KB | Share |
|
| BNCBioniche Experiences Increased Trading Activity |
| 22/04/13 | | 63.29KB | Share |
|
| BNCBioniche E. coli O157 Vaccine to be Used In Study in Sweden |
| 19/04/13 | PRICE SENSITIVE | 71.29KB | Share |
|
| BNCBioniche receive Gov't Support for 2nd Gen. E. Coli Vaccine |
| 28/03/13 | PRICE SENSITIVE | 70.24KB | Share |
|
| BNCBioniche Reacts to Canadian Federal Budget |
| 27/03/13 | PRICE SENSITIVE | 34.41KB | Share |
|
| BNCBioniche Life Sciences Reorganizes One of its Business Units |
| 08/03/13 | PRICE SENSITIVE | 254.37KB | Share |
|
| BNCAppendix 3B |
| 05/03/13 | | 112.23KB | Share |
|
| BNCVaccination of Cattle Reduces Public Health Risk of E. coli |
| 01/03/13 | | 73.24KB | Share |
|
| BNCChange of Director's Interest Notice |
| 28/02/13 | | 75.84KB | Share |
|
| BNCAppendix 3B |
| 25/02/13 | | 119.95KB | Share |
|
| BNCLetter to Shareholders, MDA, Financial Statements & Certific |
| 11/02/13 | | 387.04KB | Share |
|
| BNCBioniche Life Sciences Inc. Reports Q2, Fiscal 2013 Results |
| 07/02/13 | PRICE SENSITIVE | 130.48KB | Share |
|
| BNCChange of Director's Interest Notice |
| 07/02/13 | | 76.07KB | Share |
|
